Clinical Trials Logo

Clinical Trial Summary

A new paediatric formulation (oral liquid) has been developed for flexible and accurate dosing of valacyclovir in children. To establish the bioavailability of this new formulation, healthy volunteers will be exposed to the new formulation and to valacyclovir tablets. The concentration of valacyclovir in their blood after exposure to the oral liquid will be measured and compared to the tablet.


Clinical Trial Description

Bioequivalence of the new valcyclovir formulation will be tested according to the EMA guideline for bioequivalence. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01689285
Study type Interventional
Source Radboud University
Contact
Status Completed
Phase Phase 1
Start date December 2013
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT01682109 - Palatability Testing of a New Paediatric Formulation of Valacyclovir Phase 4
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Not yet recruiting NCT06409494 - Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years Phase 1
Recruiting NCT05532540 - Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
Recruiting NCT05604911 - Herpes Virus Infections in Kidney Transplant Patients
Not yet recruiting NCT05664152 - An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years N/A
Terminated NCT04081480 - Pharmacokinetics of Valacyclovir Oral Solution in Children N/A
Recruiting NCT04403139 - VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination Phase 4